In its lyophilized form, it should be kept cool and away from light
Most peptide users inject with U-100 insulin syringes, where 100 units = 1 mL
Safety and Research Limitations Importantly, No adequate clinical evidence defines safe human exposure, maximum tolerated dose, reproductive toxicity, carcinogenicity, genotoxicity, cardiovascular risk, liver safety, kidney safety, endocrine effects, or drug interactions
Each does different things best
INHIBIDORES DEL RECEPTOR DEL FACTOR DE CRECIMIENTO EPIDRMICO: PANITUMUMAB (VECTIBIX), CETUXIMAB (ERBITUX), ERLOTINIB (TARCEVA), GEFITINIB (IRESSA) Y LAPATINIB (TYVERB) El receptor del factor de crecimiento epidrmico (EGFR) pertenece a la familia de los receptores del factor de crecimiento epidrmico humano (HER), a la que pertenecen otros tres receptores transmembrana (HER2/neu, HER-3 y HER-4)
The most commonly observed side effects include mild injection-site irritation and nausea, which subside within the first week or two, especially at lower doses